The drug, known as Paxlovid, was approved in the United States and South Korea for emergency use in late December. The drug is a combination of the Pfizer antiviral Nirmatrelvir and the antiretroviral Ritonavir, a medication used to treat HIV. While it’s up to Health Canada, and not politicians, to determine how quickly a treatment is reviewed, Health Minister Jean-Yves Duclos said Friday that a decision could be coming soon. We obviously needed access to this drug yesterday,” Smith told the Star. “What is it that you still need that the United Kingdom and the United States didn’t require?” Smith said.

Source: thestar January 08, 2022 15:08 UTC